NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Avanza Fonder AB's Holding History (CIK: 0002035325)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 6,566 Value ($000) $230 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 7,505 Value ($000) $213 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 7,505 Value ($000) $136 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 6,205 Value ($000) $113 Avg Close $22.23 Range $17.18 - $26.80

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	6,566	$230	$36.39	$28.19 - $42.00
Q3 2025	7,505	$213	$23.97	$17.97 - $28.91
Q2 2025	7,505	$136	$18.24	$14.06 - $22.25
Q1 2025	6,205	$113	$22.23	$17.18 - $26.80